Teladoc Health Inc. (NYSE:TDOC) shares traded 3.66% higher at $24.65 on Wall Street last session.
In accordance with the data, 29 analysts cover Teladoc Health Inc. (NYSE:TDOC). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $40.00 and a low of $25.00, we find $29.00. Given the previous closing price of $23.78, this indicates a potential upside of 21.95 percent. TDOC stock price is now -3.32% away from the 50-day moving average and -11.47% away from the 200-day moving average. The market capitalization of the company currently stands at $4.09B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
It has been rated a hold by 23 analysts and a buy by 6. Brokers who have rated the stock have averaged $30.18 as their price target over the next twelve months.
In other news, Trencher Daniel, CHIEF STRATEGY OFFICER sold 1,000 shares of the company’s stock on May 17. The stock was sold for $23,810 at an average price of $23.81. Upon completion of the transaction, the CHIEF STRATEGY OFFICER now directly owns 23,520 shares in the company, valued at $0.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 04, CHIEF INNOVATION OFFICER Jensen Claus Torp sold 1,699 shares of the business’s stock. A total of $43,566 was realized by selling the stock at an average price of $25.64. This leaves the insider owning 13,540 shares of the company worth $0.33 million. Insiders disposed of 121,232 shares of company stock worth roughly $2.99 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TDOC stock. A new stake in Teladoc Health Inc. shares was purchased by QUBE RESEARCH & TECHNOLOGIES LTD during the first quarter worth $14,031,000. QUANTBOT TECHNOLOGIES LP invested $6,035,000 in shares of TDOC during the first quarter. In the first quarter, ALGERT GLOBAL LLC acquired a new stake in Teladoc Health Inc. valued at approximately $3,496,000. LEFT BRAIN WEALTH MANAGEMENT, LLC acquired a new stake in TDOC for approximately $2,903,000. JUPITER ASSET MANAGEMENT LTD purchased a new stake in TDOC valued at around $2,215,000 in the second quarter. In total, there are 662 active investors with 83.80% ownership of the company’s stock.
Teladoc Health Inc. (NYSE: TDOC) opened at $23.80 on Monday. During the past 12 months, Teladoc Health Inc. has had a low of $21.60 and a high of $44.66. As of last week, the company has a debt-to-equity ratio of 0.68, a current ratio of 3.40, and a quick ratio of 3.30. The fifty day moving average price for TDOC is $25.52 and a two-hundred day moving average price translates $27.78 for the stock.
The latest earnings results from Teladoc Health Inc. (NYSE: TDOC) was released for Mar, 2023. According to the Health Information Services Company, earnings per share came in at -$0.42, beating analysts’ expectations of -$0.5 by 0.08. This compares to -$41.58 EPS in the same period last year. The company reported revenue of $629.24 million for the quarter, compared to $565.35 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.3 percent. For the current quarter, analysts expect TDOC to generate $649.39M in revenue.
Leave a Reply